Apyx Medical receives FDA 510(k) clearance for AYON Body Contouring System

Apyx Medical Corp

AYON is the first FDA-cleared all-in-one platform combining fat removal, contouring, tissue contraction, and electrosurgery.
Initial clearance covers Renuvion for lax skin, ultrasound liposuction, electrocoagulation; power liposuction submission planned later in 2025.
Commercial launch with key opinion leader surgeons in critical geographies expected in second half of 2025.
Company highlights >15 million GLP-1 drug users as a growth driver for body contouring procedures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.